Summary
The critically ill patient occupies an increasing amount of time and bed space in modern hospital practice, and also commands increasing expenditure. Drug therapy in these patients has, in the past, been based on data derived from healthy volunteers, fit anaesthetised patients undergoing minor operative procedures, or patients with single organ failure. Alterations in pharmacokinetics and pharmacodynamics have not been studied in depth in critically ill patients who often have multisystem failure. This paper reviews the currently available information on drugs in common usage in these patients. The studies that have been performed have usually shown delayed drug clearance, altered volumes of distribution and prolonged elimination half-lives. The sedative and analgesic drugs, in particular, have shown marked accumulation which may confuse the clinical picture, and prolonged periods of assisted ventilation may be required until the drugs are eliminated.
Similar content being viewed by others
References
Aherne GW. The specificity of morphine readioimmuonassays. International Congress Symposia of the Royal Society of Medicine 58: 21–28, 1982
Aitkenhead AR, Vater K, Cooper CMS, Smith G. Pharmacokinetics of single dose I.V. morphine in normal volunteers and patients with end-stage renal failure. British Journal of Anaesthesia 56: 813–817, 1984
Alazia M, Levron JC, Guidon C, Francois G. Pharmacokinetics of fentanyl during continuous infusion in critically ill patients. Anesthesiology 67: A665, 1987
Allonen H, Zeigler G, Klotz U. Midazolam kinetics. Clinical Pharmacology and Therapeutics 30: 653–661, 1981
Amess JAL, Burman JF, Rees GM, Nancekievill DG, Mollin DL. Megaloblastic haemopoiesis in patients receiving nitrous oxide. Lancet 2: 339–342, 1978
Amos RJ, Amess JAL, Hinds CJ, Mollin DL. Incidence and pathogenesis of acute megaloblastic bone-marrow change in patients receiving intensive care. Lancet 2: 835–839, 1982
Amos RJ, Amess JAL, Nancekievill DG, Rees GM. Prevention of nitrous oxide induced megaloblastic changes in bone marrow using folinic acid. British Journal of Anaesthesia 56: 103–107, 1984
Anderson P, Boreus LO, Lilja E, Lindquist C, Ohman G. Pharmacokinetics of mannitol during neurosurgery. Acta Pharmacologica et Toxieologica 39(Suppl. V): 309, 1986
Anderson RJ, Linas SL, Berns AS, Heinrich WL, Miller JR. Non-oliguric acute renal failure. New England Journal of Medicine 296: 1134–1138, 1977
Bakti G, Fisch HU, Karlagnis G, Minder C, Bircher J. Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam. Hepatology 7: 629–638, 1987
Balant L, Dayer P, Auckenthaler R. Clinical pharmacokinetics of the third generation cephalosporins. Clinical Pharmacokinetics 10: 101–143, 1985
Ball M, McQuay HJ, Moore RA, Allen MC, Fisher A, et al. Renal failure and the use of morphine in intensive care. Lancet 1: 784, 1985
Baraka A, Gabali F. Correlation between tubocurarine requirements and plasma protein pattern. British Journal of Anaesthesia 40: 89–93, 1968
Barnes JN, Goodwin FJ. Dihydrocodeine narcosis in renal failure. British Medical Journal 286: 438–439, 1983
Barnes JN, Williams AJ, Tomson MJF, Toseland PA, Goodwin FJ. Dihydrocodeine in renal failure: further evidence for an important role of the kidney in the handling of opioid drugs. British Medical Journal 290: 740–742, 1985
Barnes JN, Williams AJ, Toseland PA, Goodwin FJ. Opioid drugs and renal failure. Lancet 2: 748, 1984
Barre J, Houin G, Bree F, Tillment JP. Disease-induced modifications of drug pharmacokinetics. International Journal of Clinical Pharmacological Research 3: 215–226, 1983
Barza M, Brown RB, Gibaldi M, Weinstein L. Predictability of blood levels of gentamicin in man. Journal of Infectious Diseases 132: 165–174, 1975
Baue A. Multiple progressive or sequential systems failure. Archives of Surgery 110: 797, 1975
Beaver WT, Wallenstein SL, Rodgers A, Houge W. Analgesic studies of codeine and oxycodone in patients with cancer, I: comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone. Journal of Pharmacology and Experimental Therapeutics 207: 92–100, 1978
Berry AJ. Respiratory support and renal function. Anesthesiology 55: 655–667, 1981
Bidwai AV, Stanley TH, Bloomer HA, Blatnick RA. Effects of anesthetic doses of morphine on renal function in the dog. Anesthesia and Analgesia 54: 357–360, 1975
Bierman MI, Brown M, Muren O, Keenan RL, Glauser FL. Prolonged isoflurane anesthesia in status asthmaticus. Critical Care Medicine 14: 832–833, 1986
Binetti M, Ascalone V, Colombi J, Zinelli L, Cisternino M. A pharmacokinetic study on midazolam in compensated liver cirrhosis. International Journal of Clinical Pharmaceutical Research 6: 405–411, 1985
Bion JF, Logan BK, Newman PM, Brodie MJ, et al. Sedation in intensive care: morphine and renal function. Intensive Care Medicine 12: 359–365, 1986
Blaschke TF. Protein binding and kinetics of drugs in liver disease. Clinical Pharmacokinetics 2: 32–44, 1977
Bodenham A, Brownlie G, Dixon JS, Park GR. Reversal of sedation by prolonged infusion of flumazenil. Anaesthesia: in press, 1988
Bokesh PM, Castaneda AR, Ziemcr G, Wilson JM. The influence of right-to-left cardiac shunts on lidocaine pharmacokinetics. Anesthesiology 67: 739–744, 1987
Bond AJ, Hailey DM, Lader MH. Plasma concentrations of benzodiazepines. British Journal of Clinical Pharmacology 4: 51–56, 1977
Borges HF, Hocks J, Kjellstand CM. Mannitol intoxication in patients with acute renal failure. Archives of Internal Medicine 12: 63–66, 1982
Bower S, Hull CJ. Comparative pharmacokinetics of fentanyl and alfentanil. British Journal of Anaesthesia 54: 871–877, 1982
Brater DC. Disposition and response to bumetanidc and furosemide. American Journal of Cardiology 57: 20A–25A, 1986
Brater D, Chennavasin P, Sewell R, Beck J. Furosemide in patients with heart failure: shift in dose response curve. Clinical Pharmacology and Therapeutics 28: 182–186, 1980
Bristow MR, Ginsburg R, Manobe W. Decreased catecholamine sensitivity and β-adrenergic density in failing human hearts. New England Journal of Medicine 307: 205–211, 1982
Brummett RE, Bendrick T, Himes D. Comparative ototoxicity of bumetanide and furosemide when used with kanamycin. Journal of Clinical Pharmacology 21: 628–636, 1981
Byalt CM, Lewis LD, Dawling S, Cochrane GM. Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit. British Medical Journal 289: 799–800, 1984
Byrne AJ, Yeoman PM, Mace P. Accumulation of midazolam in patients receiving mechanical ventilation. (Letter). British Medical Journal 289: 1309, 1984
Castledean GM, George CF, Marcer D, Hallett C. Increased sensitivity to nitrazepam in old age. British Medical Journal 1: 10–12, 1977
Chan RA, Benner EJ, Hoeprich PD. Gentamicin therapy in renal failure: a nomogram for dosage. Annals of Internal Medicine 76: 773–778, 1972
Chang KC, Bell TD, Lauer BA, Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet 1: 1132–1133, 1978
Chappie DJ, Miller AA, Ward JB, Wheatley PL. Cardiovascular and neurological effects of laudanosine: studies in mice and rats and in conscious and anaesthetised dogs. British Journal of Anaesthesia 59: 218–225, 1987
Chauvin M, Haberer JP, Ferrier C, Trouvin JG, Farinotti R, et al. Pharmacokinetics of midazolam in anaesthetised cirrhotic patients. Anesthesiology 67: A290, 1987a
Chauvin M, Sandouk P, Scherrmann JM, Farinotti R, Strumza P, et al. Morphine pharmacokinetics in renal failure. Anesthesiology 66: 327–331, 1987b
Chee TP, Sri-Prakash N, Desser KB, Benchimol A. Postoperative supraventricular arrhythmias and the role of prophylactic digoxin in cardiac surgery. American Heart Journal 104: 974–977, 1983
Chernow B, Rainey TG, Lake R. Endogenous and exogenous catecholamines in critical care medicine. Critical Care Medicine 10: 409–416, 1982
Chopra D, Janson P, Sawin CJ. Insensitivity to digoxin associated with hypocalcemia. New England Journal of Medicine 296: 917–918, 1977
Cloyd JC, Snyder BD, Cleerans B, Bundle SR. Mannitol pharmacokinetics and serum osmolality in dogs and humans. Journal of Pharmacology and Experimental Therapeutics 236: 301–306, 1986
Cockshott ID. Propofol (diprivan) pharmacokinetics and metabolism: an overview. Postgraduate Medical Journal 61(Suppl. 3): 45–50, 1985
Cone EJ, Darwin WD, Gorodetzky CW, Tan T. Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit and dog. Drug Metabolism and Disposition 6: 488–493, 1978
Coral IM, Moore AR, Strunin L. Plasma concentrations of fentanyl in normal surgical patients and those with severe renal and hepatic disease. British Journal of Anaesthesia 52: 101P, 1980
Cottrell JE, Robustelli A, Post K, Turndorf H. Furosemide and mannitol induced changes in intracranial pressure and serum osmolality and electrolytes. Anesthesiology 47: 28–30, 1977
Crul JF, Long GJ, Brunner EA, Coolen JMW. The changing pattern of neuromuscular blockade caused by succinylcholine in man. Anesthesiology 27: 729–741, 1966
Dale O, Brown Jr BR. Clinical pharmacokinetics of inhalational anaesthetics. Clinical Pharmacokinetics 12: 145–167, 1987
Daneshmend TK, Warnock DW. Clinical pharmacokinetics of systemic antifungal drugs. Clinical Pharmacokinetics 8: 17–42, 1983
Darragh A, Lambe R, Brick I, Downic WW. Reversal of benzodiazepine-induced sedation by intravenous Ro 15-1788. Lancet 1: 1042, 1981
Davis AO, Lefkowitz RJ. In vitro desensitivity of beta adrenergic receptors in human neutrophils. Journal of Clinical Investigation 71: 565–571, 1983
De Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. Journal of Antimicrobial Chemotherapy 12(Suppl. B): 29–37, 1983
Dodd MJ, O’Donnovan RM, Bennett-Jones PN, Rylance PB, Bewood M, et al. Arteriovenous haemofiltration: a recent advance in the management of renal failure. British Medical Journal 287: 1008–1010, 1983
Drayer DE, Lorenzo B. Werns S, Reidenberg M. Plasma levels, protein binding and elimination data and lidocaine and active metabolite in cardiac patients of various ages. Clinical Pharmacology and Therapeutics 34: 14–22, 1983
Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam: a review of its pharmacological properties and therapeutic use. Drugs 28: 519–543, 1984
Dundee JW, Collier PS, Carlisle RJT, Harper KW. Prolonged midazolam half life. British Journal of Pharmacology 21: 425–429, 1986
Dundee JW, Halliday NJ, Fee JPH. Midazolam in intensive care. British Medical Journal 289: 1540, 1984a
Dundee JW, Johnston HML, Gray RC. Lorazepam as a sedative-amnesic in an intensive care unit. Current Medical Research and Opinion 4: 290–295, 1976
Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam: a review of its pharmacological properties and therapeutic use. Drugs 28: 519–543, 1984b
Dundee JW, Liliburn JK, Toner W, Howard PJ. Plasma lorazepam levels. Anaesthesia 33: 15–19, 1978
Dundee JW, Price HL, Dripps RB. Acute tolerance to thiopentone in man. British Journal of Anaesthesia 28: 344–352, 1956
Dundee JW, Samuel IO, Toner W, Howard PJ. Midazolam: a water soluble benzodiazepine. Anaesthesia 35: 454–458, 1980
Ellal-Micallef R, French FF. Effect of intravenous prednisolone in asthmatics with diminished adrenergic responsiveness. Lancet 2: 1269–1271, 1975
Elliott HW. Metabolism of lorazepam. British Journal of Anaesthesia 48: 1017–1023, 1976
Endell W, Oltmanns D, Pottage T. Alteration of the kinetics of tocainide in combined hepatic and renal insufficiency. Methods and Findings in Experimental Clinical Pharmacology 5: 589–590, 1983
Fahey MR, Rupp SM, Canfell C, Fisher DM, Miller RD, et al. Effect of renal failure on laudanosine excretion in man. British Journal of Anaesthesia 57: 1049–1051, 1985
Farman JV, Turner JM, Blanlocil Y. Atracurium infusion in liver transplantation. British Journal of Anaesthesia 58: 96S–102S, 1986
Farrell G, Baird-Lambert J, Cvejic M. Disposition and metabolism of metronidazole in patients with liver failure. Hepatology 4: 722–726, 1984
Faulding S, Hall GM. Plasma analgesic concentrations: fact or fallacy. British Journal of Anaesthesia 56: 811–812, 1984
Ferrier C, Marty J, Bouttard Y, Haberer JP, Levron JC, et al. Alfentanil pharmacokinetics in patients with cirrhosis. Anesthesiology 62: 480–484, 1985
Fink M. Are diuretics useful in the treatment or prevention of acute renal failure. Southern Medical Journal 75: 329–334, 1982
Fuller R, Hoppel C, Ingalls ST. Furosemide kinetics in patients with hepatic cirrhosis and ascites. Clinical Pharmacology and Therapeutics 30: 461–467, 1981
Gabriel R. Time to scrap creatinine clearance. British Medical Journal 293: 1119–1120, 1986
Garand JJ, Regnier B, Inglebert F, Fauvisson F, Baucchet J, et al. Vancomycin pharmacokinetics in critically ill patients. Journal of Antimicrobial Chemotherapy 14(Suppl. D): 53–57, 1984
Gault MH, Jeffrey JR, Chinito E, Ward LL. Studies of digoxin dosage, kinetics and serum concentrations in renal failure. Nephron 17: 161–187, 1980
Geller E, Niv D, Silbiger AA, Halpern P, Leykin Y. et al. Ro 15-1788 in the treatment of 34 intoxicated patients. Anesthesiology 63: A157, 1985
Gelman SI. Disturbances in hepatic blood flow during anesthesia and surgery. Archives of Surgery 111: 881–883, 1976
George CF. Digoxin intoxication. British Medical Journal 286: 1533, 1983
Ghosh P, Pakrashi BC. Cardiac dysrhythmias after thoracotomy. British Heart Journal 34: 374–377, 1972
Gibson TP, Nelson HA. Drug kinetics and artificial kidneys. Clinical Pharmacokinetics 2: 403–426, 1977
Goldberg L. Dopamine: clinical uses of an endogenous catecholamine. New England Journal of Medicine 291: 707–710, 1974
Goldstein PA, Passamani ER, Roberts R. A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure. New England Journal of Medicine 303: 846–850, 1980
Gonzales-Martin G, Paulos C, Veloso B, Chesta J, Novoa X, et al. Ranitidine disposition in severe hepatic cirrhosis. International Journal of Clinical Pharmacology, Therapeutics and Toxicology 25: 139–142, 1987
Grahnen A, Jameson S, Loof L, Lindstrom B. Pharmacokinetics of cimetidine in advanced cirrhosis. European Journal of Clinical Pharmacology 26: 347–335, 1984
Graves SW, Brown B, Valdes R. An endogenous digoxin like substance in patients with renal impairment. Annals of Internal Medicine 99: 604–608, 1983
Greenacre JK, Connoly ME. Desensitisation of beta adrenoceptors from normal subjects and patients with phaeochromocytoma: studies in vivo. British Journal of Clinical Pharmacology 5: 191–197, 1978
Greenblatt DJ, Abernethy DR, Lockniskar A, Limjuco RA, Harmatz JS, et al. Effect of age, gender and obesity on midazolam kinetics. Anesthesiology 61: 27–35, 1984
Griffiths RB, Hunter JM, Jones RS. Atracurium infusions in patients with renal failure on an ITU. Anaesthesia 41: 375–381, 1985
Groeger JS, Inturrisi CE. High dose naloxone: pharmacokinetics in patients in septic shock. Critical Care Medicine 15: 751–756, 1987
Gronert GA, Theye RA. The pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 43: 89–99, 1975
Grounds RM, Lalor JM, Lumley J, Royston D, Morgan M. Propofol infusion for sedation in the intensive care unit. British Medical Journal 294: 397–400, 1987
Haberer JP, Schoeffler P, Coudere E, Duvaldestin P. Fentanyl pharmacokinetics in anaesthetised patients with cirrhosis. British Journal of Anaesthesia 54: 1267–1271, 1982
Hamdy NAT, Kennedy HJ, Nicholl J, Triger DR. Sedation for gastroscopy: a comparative study of midazolam and ‘Diazemuls’ in patients with and without cirrhosis. British Journal of Clinical Pharmacology 22: 643–647, 1986
Hanson GC, Gazzard BG. Acute stress erosions: can they be prevented? British Medical Journal 295: 348, 1987
Helmers H, Van Peer A, Woestenborghs R, Noorduin H, Heykants J. Alfentanil pharmacokinetics in elderly patients. Clinical Pharmacology and Therapeutics 36: 239–243, 1984
Henderson IS, Beattie TJ, Kemal AC. Dopamine hydrochloride in oliguric states. Lancet 2: 827–828, 1980
Henry DA, MacDonald IA, Kitchingman G, Bell GD, Langman MJS. Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. British Medical Journal 281: 775–777, 1980
Holley FO, Ponganis KV, Stanski DR. Effects of cardiac surgery with cardiopulmonary bypass on lidocaine disposition. Clinical Pharmacology and Therapeutics 35: 617–626, 1984
Hook GER. The metabolic potential of the lungs. In George & Shand (Eds) Presystcmic drug elimination, pp. 117–146, Butterworths Scientific, London, 1982
Hug C, de Lange F, Burn A. Alfentanil pharmacokinetics in patients before and after cardiopulmonary bypass. Anesthesia and Analgesia 62: 266, 1983
Idvall J, Ahlgren I, Aronsen KF, Stenberg P. Ketamine infusions: pharmacokinetics and clinical effects. British Journal of Anaesthesia 51: 1167–1173, 1979
Isherwood CN, Calvey TN, Williams NE, Chan K, Murray KR. Elimination of phenoperidine in liver disease. British Journal of Anaesthesia 56: 843–846, 1984
Jamberg PO, Bengtsson L, Ekstrand J, Hamberger B. Dopamine infusion in man, plasma catecholamine levels and pharmacokinetics. Acta Anaesthesiologica Scandinavica 25: 328–331, 1981
Jenne JW. Effect of disease states on theophylline elimination. Journal of Allergy and Clinical Immunology 78: 727–735, 1986
Jenne JW, Wyze E, Rood FS, MacDonald FM. Pharmacokinetics of theophylline: application to adjustment of the clinical dose of aminophylline. Clinical Pharmacology and Therapeutics 13: 349–360, 1972
Johannesson T, Milthers K. Morphine and normorphine in the brain of rats: a comparison of subcutaneous, intraperitoneal and intravenous administration. Acta Pharmacologica et Toxicologica 19: 241–246, 1962
Jorfeldt L, Lewis DH, Lofstrom JB, Post C. Lung uptake of lidocaine in healthy volunteers. Acta Anaesthesiologica Scandinavica 23: 567–574, 1979
Jorfeldt L, Lewis DH, Lolfstrom B, Post C. Lung uptake of lidocaine in man as influenced by anaesthetics, mepivicaine infusion or lung insufficiency. Acta Anacsthesiologica Scandinavica 27: 5–9, 1983
Kangas L, Kanto J, Forsstrom J. The protein binding of diazepam and N-desmethyldiazepam in patients with poor renal function. Clinical Nephrology 5: 114–118, 1976
Kates RE, Leier CV. Dobutamine pharmacokinetics in severe heart failure. Clinical Pharmacology and Therapeutics 24: 537–541, 1978
Keats AS. The ASA classification of physical status: a recapitulation. Anesthesiology 49: 233–236, 1978
Kleiberger E, Grimm G, Laggner A, Druml W, Lenz K, et al. Weaning patients from mechanical ventilation by benzodiazepine antagonist RO 15-1788. Lancet 2: 268–269, 1985
Klotz U. Pathophysiological and disease induced changes in drug distribution volumes: pharmacokinetic implications. Clinical Pharmacokinetics 1: 204–218, 1976
Klotz U, Kanto J. Pharmacokinetics and clinical use of flumazenil (RO 15-1788). Clinical Pharmacokinetics 14: 1–12, 1988
Klotz U, Avant GR, Wilkinson GR, Hoyumpa A, Schenkers S. Altered disposition and elimination of diazepam in patients with liver disease. Gastroenterology 65: 552, 1973
Klotz U, McHorse TS, Wilkinson GR, Schenker S. The effect of cirrhosis on the disposition and elimination of meperidine in man. Clinical Pharmacology and Therapeutics 16: 667, 1974
Knaus WA. Too sick and old for intensive care. British Journal of Hospital Medicine 37: 381, 1987
Knaus WA, Draper EA, Wagner DP, Zimmerman JP. Apache II: a severity of disease classification system. Critical Care Medicine 13: 818–829, 1985
Knight A, Bihari D, Tinker J. Stress ulceration in the critically ill patient. British Journal of Hospital Medicine 33: 216–219, 1985
Koblin DD, Waskell L, Watson JE, Stokstad ELR, Eger EI. Nitrous oxide inactivates methionine synthetase in human liver. Anesthesia and Analgesia 61: 75–78, 1982
Koch-Weser J. Serum drug concentrations as therapeutic guides. New England Journal of Medicine 287: 227–231, 1972
Koch-Weser J, Sellers EM. Binding of drugs to serum albumin. New England Journal of Medicine 294: 311–316, 526-531, 1976
Kohler L, Dellinger EP, Simmonwitz DA, Blair A, Edwards WA. Cimetidine pharmacokinetics in trauma patients. Surgical Forum 30: 12, 1979
Kraus JW, Desmond PV, Marshall JP. Effects of aging and liver disease on disposition of lorazepam. Clinical Pharmacology and Therapeutics 24: 411–419, 1978
Lambert A, Mitchell R, Frost J, Rateliffe JG, Robertson WR. Direct in vitro inhibition of adrenosteroidogenesis of etomidate. Lancet 2: 1085–1086, 1983
Lant AF. Diuretics: clinical pharmacology and therapeutic use. Drugs 29: 57–87, 162-188, 1985
Lasagna L, De Kornfield TJ. Analgesic potency of normorphine in patients with postoperative pain. Journal of Pharmacology 124: 260–263, 1958
Laskin OL. Clinical pharmacokinetics of acyclovir. Clinical Pharmacokinetics 8: 187–201, 1983
Lawler PGP, McHutchon A, Bamber PA. Potential hazards of prolonged steroid anaesthesia. (Letter). Lancet 1: 1270–1271, 1983
Ledingham I McA, McArdle CS. Prospective study of treatment of septic shock. Lancet 1: 1194–1198, 1978
Ledingham I McA, Watts I. Influence of sedation on mortality in critically ill multiple trauma patients. (Letter). Lancet 1: 1270–1271, 1983
Leier CV, Unverforth DV, Kates RE. The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiovascular failure. American Journal of Medicine 66: 238–241, 1979
Levine DF. Hypocalcacmia increases the narcotic effect of codeine. Postgraduate Medical Journal 56: 736–737, 1980
Lloyd-Thomas AR, Booker PD. Infusion of midazolam in paediatric patients after cardiac surgery. British Journal of Anaesthesia 58: 1109–1115, 1986
MacDougall BRD, Bailey RJ, Williams R. H2 receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Lancet 1: 617–619, 1977
MacNab MSP, Macrae OJ, Guy E, Grant IS, Feely J. Profound reduction in morphine clearance and liver blood flow in shock. Intensive Care Medicine 12: 366–369, 1986
Marchionni N, Pini R, Vannucci A. Hemodynamic effects of digoxin in acute myocardial infarction in man: a randomised controlled trial. American Heart Journal 109: 63–69, 1985
Marshall IG, Henderson K. Drug interactions at the neuromuscular junction. In Norman J. (Ed.) Clinics in anesthesiology, neuromuscular block, vol. 3. pp. 266–270, WB Saunders, London, 1985
Martin JA, Greenblatt DJ, Abernethy DR. Increased cimetidine clearance in burns patients. Journal of the American Medical Association 253: 1288–1291, 1985
Martin LE, Bell JA, Carey PF, Dallas FAA, Dixon GT. A review of pharmacokinetics of ranitidine in animals and man. In Misiewicz & Wormsley (Eds) The clinical use of ranitidine, pp. 22–31, Medicine Publishing Foundation, Oxford, 1982
Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clinical Pharmacokinetics 8: 422–446, 1983
Mazoit JX, Sandouk P, Zelaoui P, Scherrmann JP. Pharmacokinetics of morphine in normal and cirrhotic subjects. Anesthesia and Analgesia 66: 293–298, 1987
McClain DA, Hug CC. Intravenous fentanyl kinetics. Clinical Pharmacology and Therapeutics 28: 106–114, 1980
McDonnell TE, Bartkowski RR, Kahn C. Evidence for polymorphic oxidation of alfentanil in man. Anesthesiology 61: A284, 1982
McInderwar JC, Marshall RJ. Interaction between neuromuscular blocking drug Org NC45 and some analgesic and antimicrobial agents. British Journal of Anaesthesia 53: 785–791, 1981
McNab WR, Noomohamed FH, Brooks BA, Lant AF. Renal actions of piretanide and three other loop diuretics in man. Clinical Pharmacology and Therapeutics 35: 328–337, 1984
McQuay HJ, Bullingham RES, Moore RA. Acute opiate tolerance in man. Life Sciences 28: 2513–2517, 1981
McQuay H, Moore RA. Metabolism of narcotics. British Medical Journal 288: 237, 1984
Miller RD. Pharmacokinetics of atracurium and other non-depolarising neuromuscular blocking agents in normal patients and those with renal or hepatic dysfunction. British Journal of Anaesthesia 58: 11S–13S, 1986
Miller RD, Rupp SM, Fisher DM, et al. Clinical pharmacology of atracurium and vecuronium. Anesthesiology 61: 444–453, 1984
Mitchell MD, Wilson J, Dodek P, Russel J. Volume distribution in patients with Gram negative sepsis in the ICU. Anesthesiology 67: A126, 1987
Mitenko PA, Ogilvie RI. Rational intravenous doses of theophylline. New England Journal of Medicine 289: 600–603, 1973
Moellering RC. Pharmacokinetics of vancomycin. Journal of Antimicrobial Chemotherapy 14(Suppl. D): 43–52, 1984
Mohiuddin SM, Esterbrooks D, Hilleman DE, Patterson AJ, Sketch MH, et al. Tocainide kinetics in congestive heart failure. Clinical Pharmacology and Therapeutics 34: 596–603, 1983
Moore RA, Baldwin D, Allen MC, Watson PJO, Bullingham RES, et al. Sensitive and specific morphine radioimmunoassay with iodine label: pharmacokinetics of morphine in man after intravenous administration. Annals of Clinical Biochemistry 21: 318–325, 1984b
Moore RA, Sear JW, Baldwin D. Morphine kinetics during and after renal transplantation. Clinical Pharmacology and Therapeutics 35: 641–648, 1984c
Moore R, Smith C, Lietman P. Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. American Journal of Medicine 80: 1093–1097, 1986
Moore RD, Smith CR, Lietman PS. Association of aminoglycoside levels with therapeutic outcome in Gram negative pneumonia. American Journal of Medicine 77: 657–662, 1984a
Morcross WE, Payne JT. The induction of anaesthesia with propofol (‘Diprovan’) compared in normal and renal failure patients. Postgraduate Medical Journal 61(Suppl. 3): 62–63, 1985
Morrison G, Chiang ST, Koepke HH, Walker BR. Effect of renal impairment and hemodialysis on lorazepam kinetics. Clinical Pharmacology and Therapeutics 35: 646–652, 1984
Morrison J, Killip T. Serum digoxin and arrhythmias in patients undergoing cardiopulmonary bypass. Circulation 47: 341–352, 1973
Nattel S, Gagne G, Pineau M. The pharmacokinetics of lignocaine and β-adrenoceptor antagonists in patients with acute myocardial infarction. Clinical Pharmacokinetics 13: 293–316, 1987
Ochs HR, Greenblatt DJ, Eckardt B, et al. Repeated diazepam dosing in cirrhotic patients: cumulation and sedation. Clinical Pharmacology and Therapeutics 33: 471–476, 1983
O’Dea J, Hopkinson R. Alfentanil-midazolam infusion. Care of the Critically Ill 3: 1, 1987
Oetgen WJ, Sobol SM, Tri TB. Amiodarone-digoxin interaction: clinical and experimental observations. Chest 86: 75–79, 1984
Oltmanns D, Pottage A, Endell W. Pharmacokinetics of tocainide in patients with combined hepatic and renal dysfunction. European Journal of Clinical Pharmacology 25: 787–790, 1983
Osbourne RJ, Joel SP, Slevin ML. Morphine intoxication in renal failure: the role of morphine 6 glucuronide. British Medical Journal 292: 1548–1549, 1986
Owen J, Sitar DS, Berger L, Brownell L, Duke PC. Age related morphine kinetics. Clinical Pharmacology and Therapeutics 34: 364–368, 1983
Papper S, Saxon L, Burg MB, Seifer HW, Rosenbaum JD. The effect of morphine sulfate upon the renal excretion of water and solute in man. Journal of Laboratory and Clinical Medicine 50: 692–704, 1957
Park GR, Manara AR, Dawling S. Extrahepatic metabolism of midazolam. British Journal of Clinical Pharmacology: in press, 1988
Park GR, Manara AR, Mendel L, Bateman PE. Ketamine infusion: its use as a sedative, inotrope and bronchodilator in a critically ill patient. Anaesthesia 42: 980–983, 1987
Parker S, Carlon GC, Isaacs M, Howland WS, Kahn RC. Dopamine administration in oliguria and oliguric renal failure. Critical Care Medicine 9: 630–632, 1981
Parker SG, Thomas DG. Dihydrocodeine overdose treated with naloxone infusion. British Medical Journal 287: 1547, 1983
Patwardhan R, Johnson R, Sheehan J, Desmond P, Wilkinson G, et al. Normal metabolism of morphine in cirrhosis. Gastroenterology 81: 1005–1011, 1981
Penfold NW, Park GR. Arrhythmias related to propofol infusion. British Medical Journal 295: 556, 1987
Pentikainen PJ, Neuvonen PJ, Tarpila S, Syvalahti E. Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole. British Medical Journal 2: 861–863, 1978
Perez J, Sitar DS, Ogilvie RI. Kinetic disposition and diuretic effects of frusemide in acute pulmonary oedema. British Journal of Clinical Pharmacology 9: 471–478, 1980
Persson MP, Wiklund L, Hartvig P, Paalzow L. Potential pulmonary uptake and clearance of morphine in postoperative patients. European Journal of Clinical Pharmacology 30: 567–574, 1986
Perucca E, Grimaldi R, Crema A. Interpretation of drug levels in acute and chronic disease states. Clinical Pharmacokinetics 10: 498–513, 1985
Philbin DM, Wilson NE, Sokoloski J, Coggins C. Radioimmunoassay of antidiuretic hormone during anaesthesia. Canadian Anaesthesiologists Society Journal 23: 290–295, 1976
Piafsky KM. Disease-induced changes in plasma binding of basic drugs. Clinical Pharmacokinetics 5: 246–262, 1980
Piafsky KM, Sitar DS, Rango RE. Theophylline disposition in patients with hepatic cirrhosis. New England Journal of Medicine 60: 1495–1497, 1977a
Piafsky KM, Sitar DS, Rango RE, Ogilvie RI. Theophylline kinetics in acute pulmonary edema. Clinical Pharmacology and Therapeutics 21: 310–316, 1977b
Platt R. Adverse effects of the third generation cephalosporins. Journal of Antimicrobial Chemotherapy 19(Suppl. C): 135–140, 1982
Pollett RJ, Levy GS. Principles of membrane receptor physiology and the application to clinical medicine. Annals of Internal Medicine 92: 663–680, 1980
Polson RJ, Park GR, Lindop MJ, Farman JV, Calne RY. The prevention of renal impairment in patients undergoing orthotopic liver grafting by low dose dopamine. Anaesthesia 42: 15–19, 1987
Powell JR, Thiercelin JF, Vozeh S, Sanson L, Riegelman S. The influence of cigarette smoking and sex on theophylline disposition. American Review of Respiratory Diseases 116: 17–23, 1977
Powell JR, Vozeh S, Hopewell P, Costello J, Sheiner LB, et al. Theophylline disposition in acutely ill hospitalized patients. American Review of Respiratory Diseases 118: 229–238, 1978
Prescott LF, Adjepon-Yamoah KK, Talbot RJ. Impaired lidocaine metabolism in patients with myocardial infarction and cardiac failure. British Medical Journal 1: 939–941, 1976
Quintero E, Gines P, Arroyo V, Rimola A, Camps J, et al. Sulindac reduces urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. Nephron 42: 298–303, 1986
Rane V, Villeneuve JP, Stone WJ, Nein AS, Wilkinson GR, et al. Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia. Clinical Pharmacology and Therapeutics 24: 199–207, 1978
Redfern N. Dihydrocodeine overdose treated with naloxone infusion. British Medical Journal 287: 751–752, 1983
Reeves JG. Benzodiazepines. In Prys-Roberts & Hug (Eds) Pharmacokinetics of anaesthesia, pp. 157–186, Blackwell, Oxford 1984
Reitberg DP, Bernhard H, Schentag JJ. Alteration of theophylline clearance and half life by cimetidine in normal volunteers. Annals of Internal Medicine 95: 582–585, 1981
Robson DJ, Blow C, Gaines P, Flanagan RJ, Henry JA. Accumulation of chlormethiazole during infusion. Intensive Care Medicine 10: 315, 1984
Roerig DL, Kortly KJ, Vucins EJ, Ahlf SB, Dawson CA, et al. First pass uptake of fentanyl, meperidine and morphine in the human lung. Anesthesiology 67: 466–472, 1987
Roncari G, Ziegler WH, Guentert TW. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration. British Journal of Clinical Pharmacology 22: 421–428, 1986
Routledge PA, Bartlowsky A, Bjornsson TD, Kitchall BB, Shand DG. Lidocaine plasma protein binding. Clinical Pharmacology and Therapeutics 27: 347–354, 1980
Roux AF, Moirot E, Delhotal B, Leroy JA, Bonmarchand GP, et al. Metronidazole kinetics in patients with acute renal failure on dialysis: a cumulative study. Clinical Pharmacology and Therapeutics 36: 363–368, 1984
Rowell FJ, Seymour RA, Rawlins MD. Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. European Journal of Clinical Pharmacology 25: 419–424, 1983
Sacca L, Hendler R, Picardi A, Sherwin RS. Splanchnic and renal contribution to disposal of infused epinephrine in humans. American Journal of Physiology 251: E285–E289, 1986
Salem MG, Crooke JW, McLoughlin G, Middle JG, Taylor WH. The effect of dopamine on renal function during aortic cross clamping. Annals of the Royal College of Surgeons 70: 9–12, 1988
Salzer LB, Weinrib AB, Manina RJ, Lima JJ. A comparison of methods of lidocaine administration in patients. Clinical Pharmacology and Therapeutics 29: 617–624, 1981
Sasajima M. Analgesic effect of morphine-3-monoglucuronide. Keio Igaku 47: 421–426, 1970
Schafer A, Shafer S, Doze VA, White PF. Pharmacokinetics and pharmacodynamics of propofol infusions. Anesthesiology 67: A668, 1987
Schafer AA, White PF, Schuttler J, Rosenthal MH. Use of fentanyl infusion in the intensive care unit: tolerance to its anesthetic effects? Anesthesiology 59: 245–248, 1983
Schentag JJ, Cerra FB, Calleri GM, Leising ME, French MA, et al. Age, disease and cimetidine disposition in healthy subjects and chronically ill patients. Clinical Pharmacology and Therapeutics 29: 737–743, 1981
Schentag JJ, Jusko WJ. Renal clearance and tissue accumulation of gentamicin. Clinical Pharmacology and Therapeutics 22: 364–370, 1977
Schrier RW. Acute renal failure. Kidney International 15: 205–216, 1979
Schumach GE. Pharmacokinetic analysis of gentamicin dosage regimes for renal impairment. Journal of Clinical Pharmacology 15: 656–665, 1975
Scott DB, Beamish D, Hudson IN, Jostell KG. Prolonged infusion of chlormethiazole in intensive care. British Journal of Anaesthesia 52: 541–545, 1980
Scott JC, Stanski DR. Decreased fentanyl/alfentanil dose requirements with increasing age: a pharmacodynamic basis. Anesthesiology 63: A374, 1985
Sear JW, Fisher A, Summerfield RJ. Is alfentanil by infusion useful for sedation on the ITU. European Journal of Anaesthesiology S1: 55–61, 1987
Secor JW, Schenker S. Drug metabolism in patients with liver disease. Advances in Internal Medicine 32: 379–406, 1987
Shapiro W. Correlative studies of serum digoxin levels and arrhythmias of digoxin intoxication. American Journal of Cardiology 41: 852–859, 1978
Shelly MP, Cory EP, Park GR. Pharmacokinetics of morphine in two children before and after liver transplantation. British Journal of Anaesthesia 58: 1218–1223, 1986
Shelly MP, Mendel L, Park GR. Failure of critically ill patients to metabolise midazolam. Anaesthesia 42: 619–622, 1987
Shilo L, Shapiro MS, Doler S, Shenkman L. Endogenous digoxin like material in patients with liver disease. Annals of Internal Medicine 103: 643, 1985
Shimomura K, Kamata O, Ueki S, Ida S, Oguri K, et al. Analgesic effects of morphine glucuronides. Tohoku Journal of Experimental Medicine 105: 45–52, 1971
Simpson PJ, Eltringham RJ. Lorazepam in intensive care. Clinical Therapeutics 4: 150–163, 1981
Smith CL, Hunter JM, Jones RS. Vecuronium infusions in patients with renal failure in an ITU. Anaesthesia 42: 387–393, 1987
Smith CR, Lipsky JJ, Laskin OL, Hellman DB, Mellitts ED. Double blind comparison of nephrotoxicity and audiotoxicity of gentamicin and tobramycin. New England Journal of Medicine 302: 1106–1109, 1980
Smith DE, Gambertoglio JG, Vincenti F, Benet LZ. Furosemide kinetics and dynamics after kidney transplantation. Clinical Pharmacology and Therapeutics 30: 105–113, 1981
Smith TW, Butler VP, Haber E. Treatment of life threatening digoxin intoxication with digoxin specific Fab antibody fragments. New England Journal of Medicine 300: 1357–1362, 1982
Somogyi AA, Kong B, Gurr FW, Sabto J, Spicer WJ, et al. Metronidazole pharmacokinetics in patients with acute renal failure. Journal of Antimicrobial Chemotherapy 13: 183–189, 1984
Sonnenblick EH, Frishman WA, LeJemental JH. Dobutamine: a new synthetic cardioactive sympathetic amine. New England Journal of Medicine 300: 17–22, 1979
Stanski DR. Narcotics and naloxone. In Stanski DR (Ed.) Drug disposition in anaesthesia, pp. 137–172, Grune and Stratton, New York, 1982
Stanski DR, Greenblatt DJ, Lowenstein E. Kinetics of intravenous and intramuscular morphine. Clinical Pharmacology and Therapeutics 24: 52–59, 1978
Stewart MF, Barclay J, Warburton R. Risks of giving intravenous aminophylline to acutely ill patients receiving maintenance treatment with theophylline. British Medical Journal 288: 450, 1984
Straube PJ, Hallam PL. Ketamine by continuous infusion in status asthmaticus. Anaesthesia 41: 1017–1019, 1986
Strube PJ, Hulands GH, Halsey MJ. Serum fluoride levels in morbidly obese patients: enflurane compared with isoflurane anaesthesia. Anaesthesia 42: 685–688, 1987
Sumner WR, Michael JR, Lipsky JJ. Initial aminoglycoside levels in the critically ill. Critical Care Medicine 11: 948–950, 1983
Svensson CK, Woodruff MN, Baxter JG, Lalka D. Free drug concentration monitoring in clinical practice. Clinical Pharmacokinetics 11: 450–469, 1986
Symons IE, Emson PC, Farman JV. Endogenous opioid poisoning? British Medical Journal 284: 469–470, 1982
Szeto HH, Inturrisi CE, Houde R, Saal S, Cheigh J, et al. Accumulation of normeperidine in patients with renal failure or cancer. Annals of Internal Medicine 86: 738–741, 1977
Thompson PD, Melman KL, Richardson JA, et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease and renal failure in adults. Annals of Internal Medicine 78: 499–508, 1973
Thompson SJ, Yate PM. Bradycardia after propofol infusion. Anaesthesia 42: 430, 1987
Tilstone WJ, Fine A. Furosemide kinetics in renal failure. Clinical Pharmacology and Therapeutics 23: 644–650, 1978
Tucker GT, Mather LE. Clinical pharmacokinetics of local anaesthetics. Clinical Pharmacokinetics 4: 241–278, 1979
Unverferth DV, Blanford M, Kates RE. Tolerance to dobutamine after 72 hours continuous infusion. American Journal of Medicine 69: 262–266, 1982
Van Peer A, Vercauteren M, Noorduin H, Woestenborghs R, Heykants J. Alfentanil kinetics in renal insufficiency. European Journal of Clinical Pharmacology 30: 245–248, 1986
Vinik HR, Reves JG, Greenblatt DJ, Abernethy DR, Smith LR. The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology 59: 390–394, 1983
Warren SE, Blantz RC. Mannitol. Archives of Internal Medicine 141: 493–497, 1981
Watt I, Ledingham I McA. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 39: 973, 1984
Weiner P, Bassin MM, Jarchovsky J. Clinical course of acute atrial fibrillation treated with rapid digitalisation. American Heart Journal 105: 223, 1983
Westerfield BT, Carder AJ, Light RW. The relationship between arterial blood gases and serum theophylline clearance in critically ill patients. American Review of Respiratory Diseases 124: 17–20, 1981
Whang R, Oei TO, Watanabe A. Frequency of hypomagnesemia in hospitalised patients receiving digitalis. Archives of Internal Medicine 145: 655–656, 1985
Whittaker M. Plasma cholinesterase variants and the anaesthetist. Anaesthesia 35: 174–197, 1980
Whitwam JG, Morgan M, Hall GM, Petrie A. Pain during continuous nitrous oxide administration. British Journal of Anaesthesia 48: 425–429, 1976
Willatts SM. Paralysis for ventilated patients: yes or no? Intensive Care Medicine 11: 2–4, 1985
Williams A, Trewby P, Williams R, Reid L. Structural alterations to the pulmonary circulation in fulminant hepatic failure. Thorax 34: 477–480, 1979
Williams RL. Drug administration in hepatic disease. New England Journal of Medicine 309: 1616–1622, 1983
Williams R, Blaschke TF, Meffin P, Melman KL, Rowland M. Influence of viral hepatitis on the disposition of 2 compounds with high hepatic clearance: lidocaine and indocyanine green. Clinical Pharmacology and Therapeutics 20: 290–298, 1976
Woodcock AA, Johnson HA, Geddes DM. Theophylline prescribing, serum concentrations and toxicity. Lancet 2: 610–612, 1983
Yang JC, Clark WC, Ngai SH, Berkowitz BA, Spector S. Analgesic action and pharmacokinetics of morphine and diazepam in man. Anesthesiology 51: 495–502, 1979
Yate PM, Flynn PJ, Arnold RW, Weatherley BC, Simmonds RJ, et al. Clinical experience and plasma laudanosine concentrations during atracurium infusion in the intensive therapy unit. British Journal of Anaesthesia 59: 211–217, 1987
Yate PM, Thomas D, Short SM, Sebel PS, Morton J. Comparison of infusions of alfentanil or pethidine for sedation of ventilated patients on the ITU. British Journal of Anaesthesia 58: 1091–1099, 1986
Young CJ, Daneschund TK, Roberts CJC. Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine. Gut 23: 819–823, 1982
Zandstra DF, Stoutenbeek CP, Alexander JP. Antipyretic therapy with diclofenac sodium. Intensive Care Medicine 9: 21–22, 1983
Zarowitz BJ, Szelfer SJ, Lasezaky GM. Effect of erythromycin base on theophylline kinetics. Clinical Pharmacology and Therapeutics 29: 601–605, 1981
Zaske DE, Irvine P, Strand LM. Wide interpatient variations in gentamicin dose requirements for geriatric patients. Journal of the American Medical Association 248: 3122–3126, 1982
Zaske DE, Sawchuk RJ, Gerding DN. Increased dosage requirements of gentamicin in burns patients. Journal of Trauma 16: 824–828, 1976
Ziemanik JA, Bernhard H, Schentag JJ. Hepatic encephalopathy and altered cimetidine kinetics. Clinical Pharmacology and Therapeutics 34: 375–382, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bodenham, A., Shelly, M.P. & Park, G.R. The Altered Pharmacokinetics and Pharmacodynamics of Drugs Commonly Used in Critically Ill Patients. Clin. Pharmacokinet. 14, 347–373 (1988). https://doi.org/10.2165/00003088-198814060-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198814060-00003